A prospective phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial) - Wendler, J J; Porsch, M; Nitschke, S (Contemp Clin Trials, 2015)
et al.